Human Growth Hormone Treatment and Drug - Global and China Top Players Market Share and Ranking 2023
According to latest Research, the global market for Human Growth Hormone Treatment and Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Human Growth Hormone Treatment and Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Human Growth Hormone Treatment and Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospitals grew percent to account for percent of the total market sales, and Specialty Clinics grew percent.
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
This report studies and analyses global Human Growth Hormone Treatment and Drug status and future trends, helps the client to determine the Human Growth Hormone Treatment and Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Human Growth Hormone Treatment and Drug, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Human Growth Hormone Treatment and Drug market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Human Growth Hormone Treatment and Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Human Growth Hormone Treatment and Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Human Growth Hormone Treatment and Drug key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Human Growth Hormone Treatment and Drug key producing regions, capacity, production, and year over year growth
(6) Human Growth Hormone Treatment and Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Anhui Anke Biotechnology
Market segment by Type, covers
Powder
Solvent
Market segment by Application, can be divided into
Hospitals
Specialty Clinics
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Human Growth Hormone Treatment and Drug product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Human Growth Hormone Treatment and Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Human Growth Hormone Treatment and Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Human Growth Hormone Treatment and Drug, percent & CAGR, 2018-2029
Chapter 5: Human Growth Hormone Treatment and Drug industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Human Growth Hormone Treatment and Drug Definition
1.2 Global Human Growth Hormone Treatment and Drug Market Size and Forecast
1.2.1 By Consumption Value, Global Human Growth Hormone Treatment and Drug Market Size，2018-2029
1.2.2 By Sales Quantity, Global Human Growth Hormone Treatment and Drug Market Size，2018-2029
1.2.3 Global Human Growth Hormone Treatment and Drug Average Selling Price (ASP)，2018-2029
1.3 China Human Growth Hormone Treatment and Drug Market Size and Forecast
1.3.1 By Consumption Value, China Human Growth Hormone Treatment and Drug Market Size，2018-2029
1.3.2 By Sales Quantity, China Human Growth Hormone Treatment and Drug Market Size，2018-2029
1.3.3 China Human Growth Hormone Treatment and Drug Average Selling Price (ASP)， 2018-2029
1.4 Share of China Human Growth Hormone Treatment and Drug Market with Respect to the Global Market
1.4.1 By Consumption Value, China Human Growth Hormone Treatment and Drug Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Human Growth Hormone Treatment and Drug Market Share in Global, 2018-2029
1.4.3 Human Growth Hormone Treatment and Drug Market Size: China VS Global, 2018-2029
1.5 Human Growth Hormone Treatment and Drug Market Dynamics
1.5.1 Human Growth Hormone Treatment and Drug Market Drivers
1.5.2 Human Growth Hormone Treatment and Drug Market Restraints
1.5.3 Human Growth Hormone Treatment and Drug Industry Trends
1.5.4 Human Growth Hormone Treatment and Drug Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Human Growth Hormone Treatment and Drug, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Human Growth Hormone Treatment and Drug, Global Market Share by Company, 2018-2023
2.3 Human Growth Hormone Treatment and Drug Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Human Growth Hormone Treatment and Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Human Growth Hormone Treatment and Drug Concentration Ratio
2.6 Global Human Growth Hormone Treatment and Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Human Growth Hormone Treatment and Drug Manufacturers Product Type
2.8 Head Office and Human Growth Hormone Treatment and Drug Production Site of Key Manufacturer
2.9 Human Growth Hormone Treatment and Drug Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Human Growth Hormone Treatment and Drug, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Human Growth Hormone Treatment and Drug, China Market Share by Company, 2018-2023
3.3 China Human Growth Hormone Treatment and Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Human Growth Hormone Treatment and Drug Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Human Growth Hormone Treatment and Drug Capacity by Region
4.3 Global Human Growth Hormone Treatment and Drug Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Human Growth Hormone Treatment and Drug Production by Region, 2018-2029
4.5 Global Human Growth Hormone Treatment and Drug Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Human Growth Hormone Treatment and Drug Industry Chain
5.2 Human Growth Hormone Treatment and Drug Upstream Analysis
5.2.1 Human Growth Hormone Treatment and Drug Core Raw Materials
5.2.2 Main Manufacturers of Human Growth Hormone Treatment and Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Human Growth Hormone Treatment and Drug Production Mode
5.6 Human Growth Hormone Treatment and Drug Procurement Model
5.7 Human Growth Hormone Treatment and Drug Industry Sales Model and Sales Channels
5.7.1 Human Growth Hormone Treatment and Drug Sales Model
5.7.2 Human Growth Hormone Treatment and Drug Typical Distributors
6 Sights by Type
6.1 Human Growth Hormone Treatment and Drug Classification
6.1.1 Powder
6.1.2 Solvent
6.2 By Type, Global Human Growth Hormone Treatment and Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Human Growth Hormone Treatment and Drug Consumption Value, 2018-2029
6.4 By Type, Global Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029
6.5 By Type, Global Human Growth Hormone Treatment and Drug Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Human Growth Hormone Treatment and Drug Segment by Application
7.1.1 Hospitals
7.1.2 Specialty Clinics
7.1.3 Other
7.2 By Application, Global Human Growth Hormone Treatment and Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Human Growth Hormone Treatment and Drug Consumption Value, 2018-2029
7.4 By Application, Global Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029
7.5 By Application, Global Human Growth Hormone Treatment and Drug Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Human Growth Hormone Treatment and Drug Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Human Growth Hormone Treatment and Drug Consumption Value, 2018-2029
8.3 By Region, Global Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Human Growth Hormone Treatment and Drug & Forecasts, 2018-2029
8.4.2 By Country, North America Human Growth Hormone Treatment and Drug Market Size Market Share
8.5 Europe
8.5.1 Europe Human Growth Hormone Treatment and Drug Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Human Growth Hormone Treatment and Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Human Growth Hormone Treatment and Drug Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Human Growth Hormone Treatment and Drug Market Size Market Share
8.7 South America
8.7.1 South America Human Growth Hormone Treatment and Drug Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Human Growth Hormone Treatment and Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Human Growth Hormone Treatment and Drug Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Human Growth Hormone Treatment and Drug Consumption Value, 2018-2029
9.3 By Country, Global Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Human Growth Hormone Treatment and Drug Market Size, 2018-2029
9.4.2 By Type, U.S. Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Human Growth Hormone Treatment and Drug Market Size, 2018-2029
9.5.2 By Type, Europe Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Human Growth Hormone Treatment and Drug Market Size, 2018-2029
9.6.2 By Type, China Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Human Growth Hormone Treatment and Drug Market Size, 2018-2029
9.7.2 By Type, Japan Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Human Growth Hormone Treatment and Drug Market Size, 2018-2029
9.8.2 By Type, South Korea Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Human Growth Hormone Treatment and Drug Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Human Growth Hormone Treatment and Drug Market Size, 2018-2029
9.10.2 By Type, India Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Human Growth Hormone Treatment and Drug Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information, Head Office, Market Area, and Industry Position
10.1.2 Novo Nordisk Human Growth Hormone Treatment and Drug Models, Specifications, and Application
10.1.3 Novo Nordisk Human Growth Hormone Treatment and Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Novo Nordisk Company Profile and Main Business
10.1.5 Novo Nordisk Recent Developments
10.2 Pfizer
10.2.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.2.2 Pfizer Human Growth Hormone Treatment and Drug Models, Specifications, and Application
10.2.3 Pfizer Human Growth Hormone Treatment and Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Pfizer Company Profile and Main Business
10.2.5 Pfizer Recent Developments
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information, Head Office, Market Area, and Industry Position
10.3.2 Eli Lilly Human Growth Hormone Treatment and Drug Models, Specifications, and Application
10.3.3 Eli Lilly Human Growth Hormone Treatment and Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Eli Lilly Company Profile and Main Business
10.3.5 Eli Lilly Recent Developments
10.4 Merck Serono
10.4.1 Merck Serono Company Information, Head Office, Market Area, and Industry Position
10.4.2 Merck Serono Human Growth Hormone Treatment and Drug Models, Specifications, and Application
10.4.3 Merck Serono Human Growth Hormone Treatment and Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Merck Serono Company Profile and Main Business
10.4.5 Merck Serono Recent Developments
10.5 Roche
10.5.1 Roche Company Information, Head Office, Market Area, and Industry Position
10.5.2 Roche Human Growth Hormone Treatment and Drug Models, Specifications, and Application
10.5.3 Roche Human Growth Hormone Treatment and Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Roche Company Profile and Main Business
10.5.5 Roche Recent Developments
10.6 Ferring Pharmaceuticals
10.6.1 Ferring Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.6.2 Ferring Pharmaceuticals Human Growth Hormone Treatment and Drug Models, Specifications, and Application
10.6.3 Ferring Pharmaceuticals Human Growth Hormone Treatment and Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Ferring Pharmaceuticals Company Profile and Main Business
10.6.5 Ferring Pharmaceuticals Recent Developments
10.7 GeneScience Pharmaceuticals
10.7.1 GeneScience Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.7.2 GeneScience Pharmaceuticals Human Growth Hormone Treatment and Drug Models, Specifications, and Application
10.7.3 GeneScience Pharmaceuticals Human Growth Hormone Treatment and Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 GeneScience Pharmaceuticals Company Profile and Main Business
10.7.5 GeneScience Pharmaceuticals Recent Developments
10.8 Ipsen
10.8.1 Ipsen Company Information, Head Office, Market Area, and Industry Position
10.8.2 Ipsen Human Growth Hormone Treatment and Drug Models, Specifications, and Application
10.8.3 Ipsen Human Growth Hormone Treatment and Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Ipsen Company Profile and Main Business
10.8.5 Ipsen Recent Developments
10.9 LG Life Sciences
10.9.1 LG Life Sciences Company Information, Head Office, Market Area, and Industry Position
10.9.2 LG Life Sciences Human Growth Hormone Treatment and Drug Models, Specifications, and Application
10.9.3 LG Life Sciences Human Growth Hormone Treatment and Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 LG Life Sciences Company Profile and Main Business
10.9.5 LG Life Sciences Recent Developments
10.10 Anhui Anke Biotechnology
10.10.1 Anhui Anke Biotechnology Company Information, Head Office, Market Area, and Industry Position
10.10.2 Anhui Anke Biotechnology Human Growth Hormone Treatment and Drug Models, Specifications, and Application
10.10.3 Anhui Anke Biotechnology Human Growth Hormone Treatment and Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Anhui Anke Biotechnology Company Profile and Main Business
10.10.5 Anhui Anke Biotechnology Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Human Growth Hormone Treatment and Drug Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Human Growth Hormone Treatment and Drug Market Restraints
Table 3. Human Growth Hormone Treatment and Drug Market Trends
Table 4. Human Growth Hormone Treatment and Drug Industry Policy
Table 5. Global Human Growth Hormone Treatment and Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Human Growth Hormone Treatment and Drug Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Human Growth Hormone Treatment and Drug Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Human Growth Hormone Treatment and Drug Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Human Growth Hormone Treatment and Drug Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Human Growth Hormone Treatment and Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Human Growth Hormone Treatment and Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global Human Growth Hormone Treatment and Drug Manufacturers Product Type
Table 13. Head Office and Human Growth Hormone Treatment and Drug Production Site of Key Manufacturer
Table 14. Human Growth Hormone Treatment and Drug Capacity of Major Manufacturers and Future Plan
Table 15. China Human Growth Hormone Treatment and Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Human Growth Hormone Treatment and Drug Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Human Growth Hormone Treatment and Drug Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Human Growth Hormone Treatment and Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Human Growth Hormone Treatment and Drug Production by Region, 2018-2023, (K Units)
Table 20. Global Human Growth Hormone Treatment and Drug Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Human Growth Hormone Treatment and Drug Upstream (Raw Materials)
Table 22. Global Human Growth Hormone Treatment and Drug Typical Customers
Table 23. Human Growth Hormone Treatment and Drug Typical Distributors
Table 24. By Type, Global Human Growth Hormone Treatment and Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Human Growth Hormone Treatment and Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Human Growth Hormone Treatment and Drug Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Human Growth Hormone Treatment and Drug Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Human Growth Hormone Treatment and Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Human Growth Hormone Treatment and Drug Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Human Growth Hormone Treatment and Drug Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2018-2029
Table 34. Novo Nordisk Company Information, Head Office, Market Area, and Industry Position
Table 35. Novo Nordisk Human Growth Hormone Treatment and Drug Models, Specifications, and Application
Table 36. Novo Nordisk Human Growth Hormone Treatment and Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Novo Nordisk Company Profile and Main Business
Table 38. Novo Nordisk Recent Developments
Table 39. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 40. Pfizer Human Growth Hormone Treatment and Drug Models, Specifications, and Application
Table 41. Pfizer Human Growth Hormone Treatment and Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Pfizer Company Profile and Main Business
Table 43. Pfizer Recent Developments
Table 44. Eli Lilly Company Information, Head Office, Market Area, and Industry Position
Table 45. Eli Lilly Human Growth Hormone Treatment and Drug Models, Specifications, and Application
Table 46. Eli Lilly Human Growth Hormone Treatment and Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Eli Lilly Company Profile and Main Business
Table 48. Eli Lilly Recent Developments
Table 49. Merck Serono Company Information, Head Office, Market Area, and Industry Position
Table 50. Merck Serono Human Growth Hormone Treatment and Drug Models, Specifications, and Application
Table 51. Merck Serono Human Growth Hormone Treatment and Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Merck Serono Company Profile and Main Business
Table 53. Merck Serono Recent Developments
Table 54. Roche Company Information, Head Office, Market Area, and Industry Position
Table 55. Roche Human Growth Hormone Treatment and Drug Models, Specifications, and Application
Table 56. Roche Human Growth Hormone Treatment and Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Roche Company Profile and Main Business
Table 58. Roche Recent Developments
Table 59. Ferring Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 60. Ferring Pharmaceuticals Human Growth Hormone Treatment and Drug Models, Specifications, and Application
Table 61. Ferring Pharmaceuticals Human Growth Hormone Treatment and Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Ferring Pharmaceuticals Company Profile and Main Business
Table 63. Ferring Pharmaceuticals Recent Developments
Table 64. GeneScience Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 65. GeneScience Pharmaceuticals Human Growth Hormone Treatment and Drug Models, Specifications, and Application
Table 66. GeneScience Pharmaceuticals Human Growth Hormone Treatment and Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. GeneScience Pharmaceuticals Company Profile and Main Business
Table 68. GeneScience Pharmaceuticals Recent Developments
Table 69. Ipsen Company Information, Head Office, Market Area, and Industry Position
Table 70. Ipsen Human Growth Hormone Treatment and Drug Models, Specifications, and Application
Table 71. Ipsen Human Growth Hormone Treatment and Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Ipsen Company Profile and Main Business
Table 73. Ipsen Recent Developments
Table 74. LG Life Sciences Company Information, Head Office, Market Area, and Industry Position
Table 75. LG Life Sciences Human Growth Hormone Treatment and Drug Models, Specifications, and Application
Table 76. LG Life Sciences Human Growth Hormone Treatment and Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. LG Life Sciences Company Profile and Main Business
Table 78. LG Life Sciences Recent Developments
Table 79. Anhui Anke Biotechnology Company Information, Head Office, Market Area, and Industry Position
Table 80. Anhui Anke Biotechnology Human Growth Hormone Treatment and Drug Models, Specifications, and Application
Table 81. Anhui Anke Biotechnology Human Growth Hormone Treatment and Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Anhui Anke Biotechnology Company Profile and Main Business
Table 83. Anhui Anke Biotechnology Recent Developments
List of Figures
Figure 1. Human Growth Hormone Treatment and Drug Picture
Figure 2. Global Human Growth Hormone Treatment and Drug Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Human Growth Hormone Treatment and Drug Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Human Growth Hormone Treatment and Drug Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Human Growth Hormone Treatment and Drug Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Human Growth Hormone Treatment and Drug Sales Quantity (K Units) & (2018-2029)
Figure 7. China Human Growth Hormone Treatment and Drug Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Human Growth Hormone Treatment and Drug Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Human Growth Hormone Treatment and Drug Market Share of Global, 2018-2029
Figure 10. Global Human Growth Hormone Treatment and Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Human Growth Hormone Treatment and Drug Key Participants, Market Share, 2022
Figure 12. Global Human Growth Hormone Treatment and Drug Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Human Growth Hormone Treatment and Drug Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Human Growth Hormone Treatment and Drug Production Market Share & Forecast by Region, 2018-2029
Figure 15. Human Growth Hormone Treatment and Drug Industry Chain
Figure 16. Human Growth Hormone Treatment and Drug Procurement Model
Figure 17. Human Growth Hormone Treatment and Drug Sales Model
Figure 18. Human Growth Hormone Treatment and Drug Sales Channels, Direct Sales, and Distribution
Figure 19. Powder
Figure 20. Solvent
Figure 21. By Type, Global Human Growth Hormone Treatment and Drug Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Human Growth Hormone Treatment and Drug Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Human Growth Hormone Treatment and Drug Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Hospitals
Figure 27. Specialty Clinics
Figure 28. Other
Figure 29. By Application, Global Human Growth Hormone Treatment and Drug Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Human Growth Hormone Treatment and Drug Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Human Growth Hormone Treatment and Drug Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Human Growth Hormone Treatment and Drug Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2018-2029
Figure 36. North America Human Growth Hormone Treatment and Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Human Growth Hormone Treatment and Drug Consumption Value Market Share, 2022
Figure 38. Europe Human Growth Hormone Treatment and Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Human Growth Hormone Treatment and Drug Consumption Value Market Share, 2022
Figure 40. Asia Pacific Human Growth Hormone Treatment and Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Human Growth Hormone Treatment and Drug Consumption Value Market Share, 2022
Figure 42. South America Human Growth Hormone Treatment and Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Human Growth Hormone Treatment and Drug Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Human Growth Hormone Treatment and Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Human Growth Hormone Treatment and Drug Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Human Growth Hormone Treatment and Drug Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down A
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|